Geode Capital Management’s Braveheart Bio BRVE Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q3
$5.84M Buy
+288,798
New +$7.61M ﹤0.01% 2771

Other funds holding BRVE

Geode Capital Management's BRVE Position: Q3 2026 in Review

Geode Capital Management opened a new position in Braveheart Bio (BRVE) in Q3 2026: 288,798 shares worth $5.84M. The stake represents ﹤0.01% of the portfolio and ranks #2771 among its holdings.

64 funds tracked by Wall St. Rank hold BRVE as of Q3 2026.

  • Geode Capital Management held 288,798 shares of Braveheart Bio worth $5.84M as of Q3 2026.
  • Braveheart Bio was a new Geode Capital Management position in Q3 2026.
  • Braveheart Bio made up ﹤0.01% of Geode Capital Management's portfolio in Q3 2026, its #2771 holding.
  • 64 funds tracked by Wall St. Rank held Braveheart Bio as of Q3 2026.

Based on Geode Capital Management's 13F filing for Q3 2026, filed 6 Nov 2026.